“Cardioprotection” — Not all calcium antagonists are created equal
- 1 October 1990
- journal article
- editorial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (10) , 855-856
- https://doi.org/10.1016/0002-9149(90)90364-7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990
- Retardation of angiographic progression of coronary artery disease by nifedipineThe Lancet, 1990
- Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.BMJ, 1989
- Can the Progression of Coronary Sclerosis Be Influenced by Calcium Antagonists?Journal of Cardiovascular Pharmacology, 1989
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987The American Journal of Cardiology, 1988
- Diltiazem and Reinfarction in Patients with Non-Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1986
- Verapamil in acute myocardial infarctionEuropean Heart Journal, 1984
- Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusionJournal of Molecular and Cellular Cardiology, 1980
- A protective effect of verapamil on hypoxic heart muscleCardiovascular Research, 1976